Scleroderma Research is categorized under Medical Research in San Francisco, CA and active since 1987.
Scleroderma Research was established in 1987, and today employs 1 to 4, earning Unknown per year. This is a Medical Research business, which does work in the B2B market, and is classified as a Medical Research, under code number 5417200 by the NAICS.
If you are seeking more information, feel free to contact Deann Wright, President at the company’s single location by writing to 220 Montgomery St # 1411, San Francisco, California CA 94104 or by phoning (415) 834-9444. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Scleroderma Research |
| Contact Person: | Deann Wright, President |
| Address: | 220 Montgomery St # 1411, San Francisco, California 94104 |
| Phone Number: | (415) 834-9444 |
| Website Address: | sclerodermaresearch.org |
| Annual Revenue (USD): | Unknown |
| Founded: | 1987 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2B (Business to Business) |
| Business Category: | Medical Research |
| SIC Code: | 8733 |
| NAICS Code: | 5417200 |
| Share This Business: |
Scleroderma Research was started in 1987 to provide professional Medical Research under the SIC code 8733 and NAICS code 5417200. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of Unknown per annum.
Feel free to contact Deann Wright, President for inquiries that concern Scleroderma Research by calling the company number (415) 834-9444, as your correspondence is most welcome. Additionally, the physical location of the single location of Scleroderma Research can be found at the coordinates 37.791188,-122.402355 as well as the street address 220 Montgomery St # 1411 in San Francisco, California 94104.
For its online presence, you may visit Scleroderma Research’s website at sclerodermaresearch.org and engage with its social media outlets through on Twitter and on Facebook.